Altium Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,500	Closed	-$2.09M	–	96
2022 Q4	$2.09M	Sell	17,500 -1,500	-8%	-$179K	1.06%	33
2022 Q3	$2.02M	Sell	19,000 -3,000	-14%	-$319K	0.74%	54
2022 Q2	$2.15M	Buy	+22,000	New	+$2.15M	0.86%	45